Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MORFICUS: Ultrasound-Guided FICB with Levobupivacaine for Femoral Fractures
NCT03846102Phase 4Terminated
- Sponsor
- Zuyderland
- Start
- Jan 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levobupivacaine in Proximal femoral fracture (PFF), sponsored by Zuyderland. Started Jan 2019; status: terminated.
02
Drugs
levobupivacaine
03
Conditions
Proximal femoral fracture (PFF)
Beyond the preview
Go deeper on NCT03846102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03846102.